RECURRENT CANCER

Clinical trials for RECURRENT CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT CANCER trials appear

Sign up with your email to follow new studies for RECURRENT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet finished but already full! 3 Completed 1

Engineered immune cells take aim at Hard-to-Treat cancers

Disease control Completed

This early-stage trial tests a new type of cell therapy called CEA-targeted CAR-T for people with advanced colorectal, esophageal, stomach, or pancreatic cancers that have stopped responding to standard treatments. The therapy involves taking a patient's own immune cells, enginee…

Matched conditions: RECURRENT CANCER

Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

RECURRENT CANCER

Get alerted when new RECURRENT CANCER trials appear

Engineered immune cells take aim at Hard-to-Treat cancers